4//SEC Filing
ContraVir Pharmaceuticals, Inc. 4
Accession 0001104659-16-141912
$HEPACIK 0001583771operating
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 4:16 PM ET
Size
5.3 KB
Accession
0001104659-16-141912
Insider Transaction Report
Form 4
Cavan John T
Chief Financial Officer
Transactions
- Award
Stock Options
2016-08-26+18,688→ 118,688 totalExercise: $1.10Exp: 2026-08-26→ Common Stock (18,688 underlying)
Footnotes (1)
- [F1]Options vest in three installments as follows: 6,229 options shall vest on each of August 26, 2017 and 2018 and 6,230 shall vest on August 26, 2019.
Documents
Issuer
ContraVir Pharmaceuticals, Inc.
CIK 0001583771
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001583771
Filing Metadata
- Form type
- 4
- Filed
- Aug 28, 8:00 PM ET
- Accepted
- Aug 29, 4:16 PM ET
- Size
- 5.3 KB